Results 301 to 310 of about 1,170,145 (386)
Current Debates in Corporate Social Responsibility: An Agenda for Research
David Crowther, Esther Ortiz Martínez
openalex +1 more source
How does analyst coverage influence corporate social responsibility (CSR)? The governance- and information-based perspectives. [PDF]
Liu Y, Du X.
europepmc +1 more source
Immunosuppressive Formulations for Immunological Defense against Traumatic Brain Injury
A novel subcutaneous formulation combining alpha‐ketoglutarate, glycolysis inhibitor PFK15, and a myelin peptide reduces inflammation in a mouse TBI model. This formulation promotes regulatory immune cells, enhances autophagy, and improves motor function, suggesting its potential as a prophylactic immunosuppressive therapy to mitigate TBI‐induced ...
Kelly Lintecum+28 more
wiley +1 more source
Mapping stakeholders' relationships management in fulfilling corporate social responsibility: A study of China's construction industry. [PDF]
Zhang Y, Jiang W, Ye K, Liang Y, Wang X.
europepmc +1 more source
Pushing Radiative Cooling Technology to Real Applications
Radiative cooling controls surface optical properties for solar and thermal radiation, offering solutions for global warming and energy savings. Despite significant advances, key challenges remain: optimizing optical efficiency, maintaining aesthetics, preventing overcooling, enhancing durability, and enabling scalable production.
Chongjia Lin+8 more
wiley +1 more source
Computational Modeling of Reticular Materials: The Past, the Present, and the Future
Reticular materials are advanced materials with applications in emerging technologies. A thorough understanding of material properties at operating conditions is critical to accelerate the deployment at an industrial scale. Herein, the status of computational modeling of reticular materials is reviewed, supplemented with topical examples highlighting ...
Wim Temmerman+3 more
wiley +1 more source
Environmental corporate social responsibility practices and firm innovation: Complementarities and empirical evidence from Spanish firms. [PDF]
García-Piqueres G, García-Ramos R.
europepmc +1 more source
This work explores the MOF landscape to select a single, optimal candidate for successfully delivering cancer drugs (gemcitabine, paclitaxel, SN‐38) into tough pancreatic tumors. Machine learning and simulations guide this search, demonstrating colloidal stability, excellent biocompatibility, cellular uptake, and sustained release.
Francesca Melle+9 more
wiley +1 more source